Literature DB >> 16283082

Dysbindin (DTNBP1, 6p22.3) is associated with childhood-onset psychosis and endophenotypes measured by the Premorbid Adjustment Scale (PAS).

M C Gornick1, A M Addington, A Sporn, N Gogtay, D Greenstein, M Lenane, P Gochman, A Ordonez, R Balkissoon, R Vakkalanka, D R Weinberger, J L Rapoport, R E Straub.   

Abstract

Straub et al. (2002) recently identified the 6p22.3 gene dysbindin (DTNBP1) through positional cloning as a schizophrenia susceptibility gene. We studied a rare cohort of 102 children with onset of psychosis before age 13. Standardized ratings of early development, medication response, neuropsychological and cognitive performance, premorbid dysfunction and clinical follow-up were obtained. Fourteen SNPs were genotyped in the gene DTNBP1. Family-based pairwise and haplotype transmission disequilibrium test (TDT) analysis with the clinical phenotype, and quantitative transmission disequilibrium test (QTDT) explored endophenotype relationships. One SNP was associated with diagnosis (TDT p=.01). The QTDT analyses showed several significant relationships. Four adjacent SNPs were associated (p values=.0009-.003) with poor premorbid functioning. These findings support the hypothesis that this and other schizophrenia susceptibility genes contribute to early neurodevelopmental impairment.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16283082     DOI: 10.1007/s10803-005-0028-3

Source DB:  PubMed          Journal:  J Autism Dev Disord        ISSN: 0162-3257


  38 in total

1.  A general test of association for quantitative traits in nuclear families.

Authors:  G R Abecasis; L R Cardon; W O Cookson
Journal:  Am J Hum Genet       Date:  2000-01       Impact factor: 11.025

2.  A sib-pair regression model of linkage disequilibrium for quantitative traits.

Authors:  L R Cardon
Journal:  Hum Hered       Date:  2000 Nov-Dec       Impact factor: 0.444

3.  The schizophrenia prodrome: treatment and high-risk perspectives.

Authors:  Barbara Cornblatt; Todd Lencz; Michael Obuchowski
Journal:  Schizophr Res       Date:  2002-03-01       Impact factor: 4.939

Review 4.  Prefrontal neurons and the genetics of schizophrenia.

Authors:  D R Weinberger; M F Egan; A Bertolino; J H Callicott; V S Mattay; B K Lipska; K F Berman; T E Goldberg
Journal:  Biol Psychiatry       Date:  2001-12-01       Impact factor: 13.382

5.  Schizophrenia and schizophrenia-spectrum personality disorders in the first-degree relatives of children with schizophrenia: the UCLA family study.

Authors:  R F Asarnow; K H Nuechterlein; D Fogelson; K L Subotnik; D A Payne; A T Russell; J Asamen; H Kuppinger; K S Kendler
Journal:  Arch Gen Psychiatry       Date:  2001-06

6.  Predictors of later schizophrenia and affective psychosis among attendees at a child psychiatry department.

Authors:  M Cannon; E Walsh; C Hollis; M Kargin; E Taylor; R M Murray; P B Jones
Journal:  Br J Psychiatry       Date:  2001-05       Impact factor: 9.319

7.  Childhood-onset schizophrenia. A double-blind clozapine-haloperidol comparison.

Authors:  S Kumra; J A Frazier; L K Jacobsen; K McKenna; C T Gordon; M C Lenane; S D Hamburger; A K Smith; K E Albus; J Alaghband-Rad; J L Rapoport
Journal:  Arch Gen Psychiatry       Date:  1996-12

8.  Establishing the onset of psychotic illness.

Authors:  M Beiser; D Erickson; J A Fleming; W G Iacono
Journal:  Am J Psychiatry       Date:  1993-09       Impact factor: 18.112

9.  Strong evidence for association between the dystrobrevin binding protein 1 gene (DTNBP1) and schizophrenia in 488 parent-offspring trios from Bulgaria.

Authors:  George Kirov; Dobril Ivanov; Nigel M Williams; Anna Preece; Ivan Nikolov; Radoi Milev; Svetlinka Koleva; Albena Dimitrova; Draga Toncheva; Michael C O'Donovan; Michael J Owen
Journal:  Biol Psychiatry       Date:  2004-05-15       Impact factor: 13.382

10.  Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia.

Authors:  Cathryn M Lewis; Douglas F Levinson; Lesley H Wise; Lynn E DeLisi; Richard E Straub; Iiris Hovatta; Nigel M Williams; Sibylle G Schwab; Ann E Pulver; Stephen V Faraone; Linda M Brzustowicz; Charles A Kaufmann; David L Garver; Hugh M D Gurling; Eva Lindholm; Hilary Coon; Hans W Moises; William Byerley; Sarah H Shaw; Andrea Mesen; Robin Sherrington; F Anthony O'Neill; Dermot Walsh; Kenneth S Kendler; Jesper Ekelund; Tiina Paunio; Jouko Lönnqvist; Leena Peltonen; Michael C O'Donovan; Michael J Owen; Dieter B Wildenauer; Wolfgang Maier; Gerald Nestadt; Jean-Louis Blouin; Stylianos E Antonarakis; Bryan J Mowry; Jeremy M Silverman; Raymond R Crowe; C Robert Cloninger; Ming T Tsuang; Dolores Malaspina; Jill M Harkavy-Friedman; Dragan M Svrakic; Anne S Bassett; Jennifer Holcomb; Gursharan Kalsi; Andrew McQuillin; Jon Brynjolfson; Thordur Sigmundsson; Hannes Petursson; Elena Jazin; Tomas Zoëga; Tomas Helgason
Journal:  Am J Hum Genet       Date:  2003-06-11       Impact factor: 11.025

View more
  31 in total

1.  The neurodevelopmental model of schizophrenia: what can very early onset cases tell us?

Authors:  Judith L Rapoport; Anjene Addington; Sofia Frangou
Journal:  Curr Psychiatry Rep       Date:  2005-04       Impact factor: 5.285

Review 2.  Genetics of childhood-onset schizophrenia.

Authors:  Robert F Asarnow; Jennifer K Forsyth
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2013-07-23

Review 3.  Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia.

Authors:  John E Lisman; Joseph T Coyle; Robert W Green; Daniel C Javitt; Francine M Benes; Stephan Heckers; Anthony A Grace
Journal:  Trends Neurosci       Date:  2008-04-07       Impact factor: 13.837

4.  Brief report: no association between premorbid adjustment in adult-onset schizophrenia and genetic variation in Dysbindin.

Authors:  Frederike Schirmbeck; Alexander Georgi; Jana Strohmaier; Christine Schmael; Katja V Boesshenz; Thomas W Mühleisen; Stefan Herms; Per Hoffmann; Rami Abou Jamra; Johannes Schumacher; Wolfgang Maier; Peter Propping; Markus M Nöthen; Sven Cichon; Marcella Rietschel; Thomas G Schulze
Journal:  J Autism Dev Disord       Date:  2008-05-13

5.  Allelic heterogeneity in genetic association meta-analysis: an application to DTNBP1 and schizophrenia.

Authors:  Brion S Maher; Mark A Reimers; Brien P Riley; Kenneth S Kendler
Journal:  Hum Hered       Date:  2009-12-04       Impact factor: 0.444

Review 6.  Co-shared genetics and possible risk gene pathway partially explain the comorbidity of schizophrenia, major depressive disorder, type 2 diabetes, and metabolic syndrome.

Authors:  Teodor T Postolache; Laura Del Bosque-Plata; Serge Jabbour; Michael Vergare; Rongling Wu; Claudia Gragnoli
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2019-02-06       Impact factor: 3.568

7.  DTNBP1 (Dystrobrevin binding protein 1) and schizophrenia: association evidence in the 3' end of the gene.

Authors:  Jubao Duan; Maria Martinez; Alan R Sanders; Cuiping Hou; Gregory J Burrell; Aaron J Krasner; Daniel B Schwartz; Pablo V Gejman
Journal:  Hum Hered       Date:  2007-05-02       Impact factor: 0.444

8.  Dysbindin regulates the transcriptional level of myristoylated alanine-rich protein kinase C substrate via the interaction with NF-YB in mice brain.

Authors:  Hiroaki Okuda; Ryusuke Kuwahara; Shinsuke Matsuzaki; Shingo Miyata; Natsuko Kumamoto; Tsuyoshi Hattori; Shoko Shimizu; Kohei Yamada; Keisuke Kawamoto; Ryota Hashimoto; Masatoshi Takeda; Taiichi Katayama; Masaya Tohyama
Journal:  PLoS One       Date:  2010-01-19       Impact factor: 3.240

9.  Dysbindin-1, a schizophrenia-related protein, functionally interacts with the DNA- dependent protein kinase complex in an isoform-dependent manner.

Authors:  Satoko Oyama; Hidekuni Yamakawa; Noboru Sasagawa; Yoshio Hosoi; Eugene Futai; Shoichi Ishiura
Journal:  PLoS One       Date:  2009-01-14       Impact factor: 3.240

10.  The dysbindin-containing complex (BLOC-1) in brain: developmental regulation, interaction with SNARE proteins and role in neurite outgrowth.

Authors:  C A Ghiani; M Starcevic; I A Rodriguez-Fernandez; R Nazarian; V T Cheli; L N Chan; J S Malvar; J de Vellis; C Sabatti; E C Dell'Angelica
Journal:  Mol Psychiatry       Date:  2009-06-23       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.